A Study to Find an Efficacious and Safe Dose of CHF10067 (Zampilimab) in Participants With Idiopathic Pulmonary Fibrosis
Clinical trial NCT07516951 · RECRUITING
Trial details
- NCT number
- NCT07516951
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-08
- Primary completion
- 2028-02-12
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.